Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
Clinical trial NCT06662539 · COMPLETED
Trial details
- NCT number
- NCT06662539
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2025-09-30
- Enrollment
- 493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.